 | • レポートコード：MRC2-11QY12180 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は帯状疱疹感染症治療のグローバル市場について調査・分析したレポートです。種類別（経口、局所、非経口）市場規模、用途別（クリニック、病院、診断センター、在宅医療）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別帯状疱疹感染症治療の競争状況、市場シェア ・世界の帯状疱疹感染症治療市場：種類別市場規模 2015年-2020年（経口、局所、非経口） ・世界の帯状疱疹感染症治療市場：種類別市場規模予測 2021年-2026年（経口、局所、非経口） ・世界の帯状疱疹感染症治療市場：用途別市場規模 2015年-2020年（クリニック、病院、診断センター、在宅医療） ・世界の帯状疱疹感染症治療市場：用途別市場規模予測 2021年-2026年（クリニック、病院、診断センター、在宅医療） ・北米の帯状疱疹感染症治療市場分析：米国、カナダ ・ヨーロッパの帯状疱疹感染症治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの帯状疱疹感染症治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の帯状疱疹感染症治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの帯状疱疹感染症治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bausch Health、Camber Pharmaceuticals、Novartis、Teva Pharmaceutical、Abbott、Merck ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Herpes Zoster (shingles) is a cutaneous, acute viral infection caused by the varicella-zoster virus. Herpes Zoster is the outbreak of rash on the skin that cause burning and pain. Herpes Zoster is caused by the same virus which cause chickenpox. The virus may live in your nervous system for many years after the occurrence of chicken pox infection and is as reactive as Herpes Zoster.
Chickenpox is caused by initial infection of VZV virus, after chicken pox is resolved the virus remains inactive in the nerve cells. The virus gets reactive travels to the nerve end producing blisters. The rash increases within two or three weeks. Herpes zoster appear as blisters on one side of the body usually on neck, face or torso. Some symptoms beyond pain and rashes are fever, headache, fatigue and muscles weakness. Person who had chicken pox is at risk of herpes zoster. The person with the herpes zoster can pass on the virus to someone else who never had chicken pox, but the person will develop chicken pox and not herpes zoster.
Market Analysis and Insights: Global Herpes Zoster Infection Treatment Market
The global Herpes Zoster Infection Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Herpes Zoster Infection Treatment Scope and Market Size
Herpes Zoster Infection Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Herpes Zoster Infection Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Bausch Health
Camber Pharmaceuticals
Novartis
Teva Pharmaceutical
Abbott
Merck
…
Market segment by Type, the product can be split into
Oral
Topical
Parental
Market segment by Application, split into
Clinics
Hospitals
Diagnostic centers
Home Care
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Herpes Zoster Infection Treatment Revenue
1.4 Market by Type
1.4.1 Global Herpes Zoster Infection Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral
1.4.3 Topical
1.4.4 Parental
1.5 Market by Application
1.5.1 Global Herpes Zoster Infection Treatment Market Share by Application: 2020 VS 2026
1.5.2 Clinics
1.5.3 Hospitals
1.5.4 Diagnostic centers
1.5.5 Home Care
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Herpes Zoster Infection Treatment Market Perspective (2015-2026)
2.2 Global Herpes Zoster Infection Treatment Growth Trends by Regions
2.2.1 Herpes Zoster Infection Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Herpes Zoster Infection Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Herpes Zoster Infection Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Herpes Zoster Infection Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Herpes Zoster Infection Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Herpes Zoster Infection Treatment Players by Market Size
3.1.1 Global Top Herpes Zoster Infection Treatment Players by Revenue (2015-2020)
3.1.2 Global Herpes Zoster Infection Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Herpes Zoster Infection Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Herpes Zoster Infection Treatment Market Concentration Ratio
3.2.1 Global Herpes Zoster Infection Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Herpes Zoster Infection Treatment Revenue in 2019
3.3 Herpes Zoster Infection Treatment Key Players Head office and Area Served
3.4 Key Players Herpes Zoster Infection Treatment Product Solution and Service
3.5 Date of Enter into Herpes Zoster Infection Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Herpes Zoster Infection Treatment Historic Market Size by Type (2015-2020)
4.2 Global Herpes Zoster Infection Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Herpes Zoster Infection Treatment Market Size by Application (2015-2020)
5.2 Global Herpes Zoster Infection Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Herpes Zoster Infection Treatment Market Size (2015-2020)
6.2 Herpes Zoster Infection Treatment Key Players in North America (2019-2020)
6.3 North America Herpes Zoster Infection Treatment Market Size by Type (2015-2020)
6.4 North America Herpes Zoster Infection Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Herpes Zoster Infection Treatment Market Size (2015-2020)
7.2 Herpes Zoster Infection Treatment Key Players in Europe (2019-2020)
7.3 Europe Herpes Zoster Infection Treatment Market Size by Type (2015-2020)
7.4 Europe Herpes Zoster Infection Treatment Market Size by Application (2015-2020)
8 China
8.1 China Herpes Zoster Infection Treatment Market Size (2015-2020)
8.2 Herpes Zoster Infection Treatment Key Players in China (2019-2020)
8.3 China Herpes Zoster Infection Treatment Market Size by Type (2015-2020)
8.4 China Herpes Zoster Infection Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Herpes Zoster Infection Treatment Market Size (2015-2020)
9.2 Herpes Zoster Infection Treatment Key Players in Japan (2019-2020)
9.3 Japan Herpes Zoster Infection Treatment Market Size by Type (2015-2020)
9.4 Japan Herpes Zoster Infection Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Herpes Zoster Infection Treatment Market Size (2015-2020)
10.2 Herpes Zoster Infection Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Herpes Zoster Infection Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Herpes Zoster Infection Treatment Market Size by Application (2015-2020)
11 India
11.1 India Herpes Zoster Infection Treatment Market Size (2015-2020)
11.2 Herpes Zoster Infection Treatment Key Players in India (2019-2020)
11.3 India Herpes Zoster Infection Treatment Market Size by Type (2015-2020)
11.4 India Herpes Zoster Infection Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Herpes Zoster Infection Treatment Market Size (2015-2020)
12.2 Herpes Zoster Infection Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Herpes Zoster Infection Treatment Market Size by Type (2015-2020)
12.4 Central & South America Herpes Zoster Infection Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Bausch Health
13.1.1 Bausch Health Company Details
13.1.2 Bausch Health Business Overview
13.1.3 Bausch Health Herpes Zoster Infection Treatment Introduction
13.1.4 Bausch Health Revenue in Herpes Zoster Infection Treatment Business (2015-2020))
13.1.5 Bausch Health Recent Development
13.2 Camber Pharmaceuticals
13.2.1 Camber Pharmaceuticals Company Details
13.2.2 Camber Pharmaceuticals Business Overview
13.2.3 Camber Pharmaceuticals Herpes Zoster Infection Treatment Introduction
13.2.4 Camber Pharmaceuticals Revenue in Herpes Zoster Infection Treatment Business (2015-2020)
13.2.5 Camber Pharmaceuticals Recent Development
13.3 Novartis
13.3.1 Novartis Company Details
13.3.2 Novartis Business Overview
13.3.3 Novartis Herpes Zoster Infection Treatment Introduction
13.3.4 Novartis Revenue in Herpes Zoster Infection Treatment Business (2015-2020)
13.3.5 Novartis Recent Development
13.4 Teva Pharmaceutical
13.4.1 Teva Pharmaceutical Company Details
13.4.2 Teva Pharmaceutical Business Overview
13.4.3 Teva Pharmaceutical Herpes Zoster Infection Treatment Introduction
13.4.4 Teva Pharmaceutical Revenue in Herpes Zoster Infection Treatment Business (2015-2020)
13.4.5 Teva Pharmaceutical Recent Development
13.5 Abbott
13.5.1 Abbott Company Details
13.5.2 Abbott Business Overview
13.5.3 Abbott Herpes Zoster Infection Treatment Introduction
13.5.4 Abbott Revenue in Herpes Zoster Infection Treatment Business (2015-2020)
13.5.5 Abbott Recent Development
13.6 Merck
13.6.1 Merck Company Details
13.6.2 Merck Business Overview
13.6.3 Merck Herpes Zoster Infection Treatment Introduction
13.6.4 Merck Revenue in Herpes Zoster Infection Treatment Business (2015-2020)
13.6.5 Merck Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Herpes Zoster Infection Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Herpes Zoster Infection Treatment Revenue
Table 3. Ranking of Global Top Herpes Zoster Infection Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Herpes Zoster Infection Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral
Table 6. Key Players of Topical
Table 7. Key Players of Parental
Table 8. Global Herpes Zoster Infection Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Herpes Zoster Infection Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Herpes Zoster Infection Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Herpes Zoster Infection Treatment Market Share by Regions (2015-2020)
Table 12. Global Herpes Zoster Infection Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Herpes Zoster Infection Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Herpes Zoster Infection Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Herpes Zoster Infection Treatment Players
Table 19. Global Herpes Zoster Infection Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Herpes Zoster Infection Treatment Market Share by Players (2015-2020)
Table 21. Global Top Herpes Zoster Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Zoster Infection Treatment as of 2019)
Table 22. Global Herpes Zoster Infection Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Herpes Zoster Infection Treatment Product Solution and Service
Table 25. Date of Enter into Herpes Zoster Infection Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Herpes Zoster Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Herpes Zoster Infection Treatment Market Size Share by Type (2015-2020)
Table 29. Global Herpes Zoster Infection Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Herpes Zoster Infection Treatment Market Size Share by Application (2015-2020)
Table 31. Global Herpes Zoster Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Herpes Zoster Infection Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Herpes Zoster Infection Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Herpes Zoster Infection Treatment Market Share (2019-2020)
Table 35. North America Herpes Zoster Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Herpes Zoster Infection Treatment Market Share by Type (2015-2020)
Table 37. North America Herpes Zoster Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Herpes Zoster Infection Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Herpes Zoster Infection Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Herpes Zoster Infection Treatment Market Share (2019-2020)
Table 41. Europe Herpes Zoster Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Herpes Zoster Infection Treatment Market Share by Type (2015-2020)
Table 43. Europe Herpes Zoster Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Herpes Zoster Infection Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Herpes Zoster Infection Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Herpes Zoster Infection Treatment Market Share (2019-2020)
Table 47. China Herpes Zoster Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Herpes Zoster Infection Treatment Market Share by Type (2015-2020)
Table 49. China Herpes Zoster Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Herpes Zoster Infection Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Herpes Zoster Infection Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Herpes Zoster Infection Treatment Market Share (2019-2020)
Table 53. Japan Herpes Zoster Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Herpes Zoster Infection Treatment Market Share by Type (2015-2020)
Table 55. Japan Herpes Zoster Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Herpes Zoster Infection Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Herpes Zoster Infection Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Herpes Zoster Infection Treatment Market Share (2019-2020)
Table 59. Southeast Asia Herpes Zoster Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Herpes Zoster Infection Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Herpes Zoster Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Herpes Zoster Infection Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Herpes Zoster Infection Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Herpes Zoster Infection Treatment Market Share (2019-2020)
Table 65. India Herpes Zoster Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Herpes Zoster Infection Treatment Market Share by Type (2015-2020)
Table 67. India Herpes Zoster Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Herpes Zoster Infection Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Herpes Zoster Infection Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Herpes Zoster Infection Treatment Market Share (2019-2020)
Table 71. Central & South America Herpes Zoster Infection Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Herpes Zoster Infection Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Herpes Zoster Infection Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Herpes Zoster Infection Treatment Market Share by Application (2015-2020)
Table 75. Bausch Health Company Details
Table 76. Bausch Health Business Overview
Table 77. Bausch Health Product
Table 78. Bausch Health Revenue in Herpes Zoster Infection Treatment Business (2015-2020) (Million US$)
Table 79. Bausch Health Recent Development
Table 80. Camber Pharmaceuticals Company Details
Table 81. Camber Pharmaceuticals Business Overview
Table 82. Camber Pharmaceuticals Product
Table 83. Camber Pharmaceuticals Revenue in Herpes Zoster Infection Treatment Business (2015-2020) (Million US$)
Table 84. Camber Pharmaceuticals Recent Development
Table 85. Novartis Company Details
Table 86. Novartis Business Overview
Table 87. Novartis Product
Table 88. Novartis Revenue in Herpes Zoster Infection Treatment Business (2015-2020) (Million US$)
Table 89. Novartis Recent Development
Table 90. Teva Pharmaceutical Company Details
Table 91. Teva Pharmaceutical Business Overview
Table 92. Teva Pharmaceutical Product
Table 93. Teva Pharmaceutical Revenue in Herpes Zoster Infection Treatment Business (2015-2020) (Million US$)
Table 94. Teva Pharmaceutical Recent Development
Table 95. Abbott Company Details
Table 96. Abbott Business Overview
Table 97. Abbott Product
Table 98. Abbott Revenue in Herpes Zoster Infection Treatment Business (2015-2020) (Million US$)
Table 99. Abbott Recent Development
Table 100. Merck Company Details
Table 101. Merck Business Overview
Table 102. Merck Product
Table 103. Merck Revenue in Herpes Zoster Infection Treatment Business (2015-2020) (Million US$)
Table 104. Merck Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Herpes Zoster Infection Treatment Market Share by Type: 2020 VS 2026
Figure 2. Oral Features
Figure 3. Topical Features
Figure 4. Parental Features
Figure 5. Global Herpes Zoster Infection Treatment Market Share by Application: 2020 VS 2026
Figure 6. Clinics Case Studies
Figure 7. Hospitals Case Studies
Figure 8. Diagnostic centers Case Studies
Figure 9. Home Care Case Studies
Figure 10. Herpes Zoster Infection Treatment Report Years Considered
Figure 11. Global Herpes Zoster Infection Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Herpes Zoster Infection Treatment Market Share by Regions: 2020 VS 2026
Figure 13. Global Herpes Zoster Infection Treatment Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Herpes Zoster Infection Treatment Market Share by Players in 2019
Figure 16. Global Top Herpes Zoster Infection Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herpes Zoster Infection Treatment as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Herpes Zoster Infection Treatment Revenue in 2019
Figure 18. North America Herpes Zoster Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Herpes Zoster Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Herpes Zoster Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Herpes Zoster Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Herpes Zoster Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Herpes Zoster Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Herpes Zoster Infection Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
水痘帯状疱疹感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Varicella Zoster Infection Treatment Drugs Market The global Varicella Zoster Infection Treatment Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Varicella Zoster Infection Tr…- 水痘帯状疱疹ウイルス（VZV）治療の世界市場（～2026年） Market Analysis and Insights: Global Varicella-Zoster Virus (VZV) Treatment Market The global Varicella-Zoster Virus (VZV) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Varicella-Zoster Virus (VZV) Treatmen…
- 口唇ヘルペス治療の世界市場（～2026年） Market Analysis and Insights: Global Herpes Labialis Treatment Market The global Herpes Labialis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Herpes Labialis Treatment Scope and Market Size Herpes Labialis…
- 耳感染症治療の世界市場（～2026年） An ear infection occurs due to invasion by bacteria or virus causing pain, inflammation and fluid build-up in the ear. Most ear infections are acute but chronic ear infections can cause permanent damage to the middle and inner ear. Eustachian tubes, small tubes running from ear to the back of the th…
- 口唇ヘルペス治療・予防の世界市場（～2026年） Market Analysis and Insights: Global Treatment and Prevention of Herpes Labialis Market The global Treatment and Prevention of Herpes Labialis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Treatment and Prevention of…